To investigate the role of MGMT in PanNET progression, we examined the expression level of MGMT in various human and mouse pancreatic cancer cell lines (SPNE1, NIT‐1, QGP‐1, Beta‐TC6, MIN6, and Bon‐1). This evidence concerns the gene NIT1 and familial pancreatic carcinoma.